HL23, CAS [[1448355-15-4]]

Produktübersicht

• Artikelname: HL23, CAS [[1448355-15-4]]
• Artikelnummer: MCE-HY-155248
• Hersteller Artikelnummer: HY-155248
• Alternativnummer: MCE-HY-155248-100MG,MCE-HY-155248-50MG,MCE-HY-155248-5MG,MCE-HY-155248-10MG,MCE-HY-155248-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

HL23 is a histone deacetylase (HDAC) inhibitor with activity against hepatocellular carcinoma (HCC). HL23 enhances acetylation of the TXNIP promoter and upregulates TXNIP expression, thereby mediating potassium channel activity and triggering TXNIP-dependent potassium deprivation. HL23 inhibits HCC progression and metastasis and has a synergistic effect with Sorafenib (HY-10201) and is more potent than Sorafenib+Vorinostat (HY-10221)[1].

Produkteigenschaften

• Molekulargewicht: 712.83
• Reinheit: 99.64
• CAS Nummer: [1448355-15-4]
• Formel: C44H44N2O7
• Target-Kategorie: HDAC

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound